Julie Novakova Martinkova

Julie Novakova Martinkova

Auto-generated profile, based on publicly available information

Julie Novakova Martinkova

Cognitive Center, Department of Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 February 2020 in European Journal of Neurology
Verified
Journal Article
Closed access
PDF file
MFMaria Teresa Ferretti
Maria Teresa Ferretti
JMJulie Martinkova
Julie Martinkova
Evelyne BischofEvelyne Bischof
Evelyne Bischof
TBThomas Benke
Thomas Benke
GGGino Gialdini
Gino Gialdini
RSReinhold Schmidt
Reinhold Schmidt

14 April 2025 in Nature Reviews Neurology
Verified
Journal Article
Closed access
PDF file
LCLaura Castro-Aldrete
Laura Castro-Aldrete
MEMelanie Einsiedler
Melanie Einsiedler
JMJulie Novakova Martinkova
Julie Novakova Martinkova
HDHerman Depypere
Herman Depypere
TATing Fang Alvin Ang
Ting Fang Alvin Ang
ACAntonella Santuccione Chadha
Antonella Santuccione Chadha

8 March 2023 in Frontiers in Psychiatry
Verified
Journal Article
Open access
JMJulie Novakova Martinkova
Julie Novakova Martinkova
MFMaria Teresa Ferretti
Maria Teresa Ferretti
AFAlberto Ferrari
Alberto Ferrari
OLOndrej Lerch
Ondrej Lerch
VMVeronika Matuskova
Veronika Matuskova
FIFor The Alzheimer’s Disease Neuroimaging Initiative
For The Alzheimer’s Disease Neuroimaging Initiative
Introduction: Choroid plexus (CP)-related mechanisms have been implicated in the pathogenesis of neurodegenerative diseases, including Alzheimer’s disease. In this pilot study, we aimed to elucidate the association between longitudinal changes in CP volume, sex and cognitive impairment.Methods: We assessed longitudinal changes in CP volume in a cohort of n = 613 subjects across n = 2,334 datapoints from ADNI 2 and ADNI-GO, belonging to cognitively unimpaired (CN), stable mild cognitive impairment (MCI), clinically diagnosed Alzheimer’s disease dementia (AD) or convertor (to either AD or MCI) subgroups. CP volume was automatically segmented and used as a response variable in linear mixed effect models with random intercept clustered by patient identity. Temporal effects of select variables were assessed by interactions and subgroup analyses.Results: We found an overall significant increase of CP volume in time (14.92 mm3 per year, 95% confidence interval, CI (11.05, 18.77), p < 0.001). Sex-disaggregated results showed an annual rate of increase 9.48 mm3 in males [95% CI (4.08, 14.87), p < 0.001], and 20.43 mm3 in females [95% CI (14.91, 25.93), p < 0.001], indicating more than double the rate of increase in females, which appeared independent of other temporal variables. The only diagnostic group with a significant CP increase as compared to CN was the convertors group, with an increase of 24.88 mm3/year [95% CI (14, 35.82), p < 0.001]. ApoE exhibited a significant temporal effect, with the E4 homozygote group’s CP increasing at more than triple the rate of non-carrier or heterozygote groups [40.72, 95% CI (25.97, 55.46), p < 0.001 vs. 12.52, 95% CI (8.02, 17.02), p < 0.001 for ApoE E4 homozygotes and E4 non-carriers, respectively], and may have modified the diagnostic group relationship.Conclusion: Our results contribute to potential mechanisms for sex differences in cognitive impairment with a novel finding of twice the annual choroid plexus enlargement in females and provide putative support for CP-related mechanisms of cognitive deterioration and its relationship to ApoE E4.